cry! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also helps with weight loss. Known as “triple-G,” injectable retatretide has triple hits on the GLP-1, GIP, and glucagon hormones, while most other drugs on the market only mimic one or two of these hormones. Eli Lilly’s new retatretide drug … Read more
Three is still the magic number for pharmacy benefit managers (PBMs). By 2025, 80% of all prescription claims will be processed by three companies: CVS Health’s CVS Caremark business, Cigna’s Express Scripts business, and UnitedHealth Group’s Optum Rx business. Express Scripts continued to pull ahead of its peers, while CVS Caremark’s claim volume declined for … Read more
The U.S. Food and Drug Administration announced Thursday that it is approving a new, high-dose Vigovi (semglutide) injection. The 7.2 mg dose, called Vigovi HD, is intended for weight loss and long-term weight loss maintenance in adult patients. This is three times the previous maximum dose of 2.4 mg. This marks the fourth approval in … Read more